IQGAP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.35800309570322E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.12919995576277E-09 |
Normal-vs-Stage2 |
1.595270E-04 |
Normal-vs-Stage3 |
2.27673435659881E-12 |
Normal-vs-Stage4 |
2.24065210829849E-12 |
Stage1-vs-Stage2 |
2.868000E-01 |
Stage1-vs-Stage3 |
2.0741999999907E-05 |
Stage1-vs-Stage4 |
3.563400E-04 |
Stage2-vs-Stage3 |
1.114190E-02 |
Stage2-vs-Stage4 |
9.002600E-03 |
Stage3-vs-Stage4 |
7.011800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.0284995077825E-10 |
Normal-vs-AfricanAmerican |
2.13799977721862E-10 |
Normal-vs-Asian |
4.446800E-04 |
Caucasian-vs-AfricanAmerican |
2.243800E-01 |
Caucasian-vs-Asian |
9.295600E-01 |
AfricanAmerican-vs-Asian |
7.270200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.67410554705339E-11 |
Normal-vs-Female |
4.37820002474609E-10 |
Male-vs-Female |
3.275800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.69972932898099E-12 |
Normal-vs-Age(41-60Yrs) |
8.0978002081622E-10 |
Normal-vs-Age(61-80Yrs) |
4.22449852877094E-11 |
Normal-vs-Age(81-100Yrs) |
4.41070002743515E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.378800E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.478400E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.697350E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.833240E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.261000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.000600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.43690000000441E-05 |
Normal-vs-Grade 2 |
1.50669998699726E-09 |
Normal-vs-Grade 3 |
2.1949997375259E-11 |
Normal-vs-Grade 4 |
8.99280649946377E-15 |
Grade 1-vs-Grade 2 |
7.084800E-01 |
Grade 1-vs-Grade 3 |
1.784820E-01 |
Grade 1-vs-Grade 4 |
1.778780E-03 |
Grade 2-vs-Grade 3 |
2.553600E-02 |
Grade 2-vs-Grade 4 |
5.20059999509215E-08 |
Grade 3-vs-Grade 4 |
1.435240E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.78959999544526E-08 |
Normal-vs-ccB subtype |
2.29509744542611E-11 |
ccA subtype-vs-ccB subtype |
3.834300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.10970019232093E-10 |
Normal-vs-N1 |
4.94071450418687E-12 |
N0-vs-N1 |
2.358300E-03 |
|
|